Recombinant Chicken CD166 antigen (ALCAM)

What is Chicken CD166 antigen (ALCAM) and what are its key structural features?

Chicken CD166 antigen, also known as Activated Leukocyte Cell Adhesion Molecule (ALCAM), is a transmembrane glycoprotein belonging to the immunoglobulin superfamily. In chicken, it's also referred to as BEN glycoprotein, DM-GRASP, Protein JC7, or SC1 glycoprotein . ALCAM functions as a cell adhesion molecule that mediates both heterotypic and homotypic cell-cell contacts .

Key structural features include:

• Type I transmembrane glycoprotein with molecular weight of approximately 100-110 kDa

• Contains multiple immunoglobulin-like domains in its extracellular region

• Structure includes signal peptide, extracellular domain with Ig-like domains, transmembrane domain, and cytoplasmic domain

• The extracellular domain contains two V-type and three C2-type Ig-like domains, similar to the arrangement in mammalian ALCAM proteins

This structural organization facilitates ALCAM's diverse functions in cell adhesion, immune responses, and developmental processes across various chicken tissues and cell types.

How does Chicken ALCAM compare structurally to mammalian ALCAM proteins?

Chicken ALCAM shares significant structural homology with mammalian ALCAM proteins but maintains species-specific characteristics. Structurally, both avian and mammalian ALCAM proteins follow a similar domain organization pattern.

The mouse ALCAM contains 583 amino acids, including a 27 amino acid signal peptide, 500 amino acid extracellular domain, 22 amino acid transmembrane domain, and 34 amino acid cytoplasmic domain . Human ALCAM has a similar structure, with the extracellular domain spanning from Trp28 to Ala526 .

While the search results don't provide specific sequence identity between chicken and human ALCAM, we can note that mouse ALCAM's extracellular domain shares 93% amino acid sequence identity with human/porcine ALCAM . This high conservation suggests that chicken ALCAM likely maintains similar structural features while having species-specific variations in certain domains.

The conservation of structural domains across species reflects the evolutionary importance of ALCAM's functions, particularly in immune cell interactions and developmental processes, which are fundamental across vertebrate species.

What are the primary functions of ALCAM in chicken immune and developmental systems?

ALCAM performs several crucial functions in chicken immune and developmental systems:

In immune regulation, ALCAM promotes T-cell activation and proliferation through its interactions with CD6 . It contributes to the formation and maturation of the immunological synapse via these CD6 interactions, creating a stable platform for sustained T-cell signaling . The protein also mediates both heterotypic cell-cell contacts through CD6 binding and homotypic contacts between ALCAM-expressing cells .

For developmental processes, ALCAM likely plays important roles in the developing nervous system, similar to its mammalian counterparts. Studies on ALCAM in other species suggest it may influence expression or adhesion of the neuronal adhesion molecule NCAM-L1, both in the developing retina and in other neural tissues .

These functions highlight ALCAM's versatility as both an immune regulator and a developmental factor in chicken biology, making it a valuable target for researchers investigating these interconnected biological systems.

Which tissues and cell types express ALCAM in chickens?

Based on the available information and comparative analysis with mammalian systems, ALCAM expression in chickens is found in multiple tissues and cell types:

• Thymic epithelium, where it likely participates in T-cell development

• Microvascular endothelium, contributing to vascular barrier functions and leukocyte interactions

• Activated lymphocytes, particularly T cells engaged in immune responses

• Monocytes and monocyte-derived dendritic cells, where it mediates antigen presentation functions

• Neural tissues, especially during embryonic development

This diverse expression pattern reflects ALCAM's multifunctional nature in chicken physiology. The protein likely shows dynamic expression during development, with temporal and spatial regulation that coordinates with specific developmental and immunological processes. Understanding this expression pattern is essential for researchers designing experiments to study ALCAM function in specific chicken tissues.

How does recombinant Chicken ALCAM interact with CD6 and other binding partners?

Recombinant Chicken ALCAM engages in both heterotypic and homotypic interactions that regulate cellular processes:

The heterotypic interaction with CD6 is particularly significant for immune function. ALCAM binds CD6 primarily through its N-terminal immunoglobulin domains, creating a stable adhesion that supports T-cell activation and proliferation . This interaction contributes to the formation and maturation of the immunological synapse, enhancing T-cell receptor signaling and downstream activation events .

For homotypic interactions, ALCAM molecules on opposing cells bind to each other through their immunoglobulin domains. These ALCAM-ALCAM interactions establish adhesive contacts between cells expressing this protein, contributing to tissue architecture and cellular organization .

In tumor biology contexts, ALCAM interacts with endothelial cells, potentially facilitating tumor cell adhesion to vascular surfaces. Studies in pancreatic cancer demonstrate that ALCAM mediates tumor-endothelial cell interactions and enhances tumor embolism, suggesting similar mechanisms may operate in avian tumor models .

These diverse binding interactions make recombinant ALCAM a valuable tool for studying adhesion-dependent processes in multiple chicken tissue and cell types.

How do researchers distinguish between membrane-bound and soluble forms of Chicken ALCAM?

Distinguishing between membrane-bound and soluble forms of Chicken ALCAM requires specific methodological approaches:

For membrane-bound ALCAM, immunofluorescence microscopy provides cellular localization information. As demonstrated with human ALCAM, specific staining can be localized to the cell surface using appropriate antibodies . Flow cytometry similarly detects surface-expressed ALCAM on intact cells and can quantify expression levels across different cell populations .

Soluble ALCAM detection typically employs ELISA-based methods. Commercial kits like the Chicken CD166 antigen (ALCAM) ELISA Kit can detect ALCAM in serum, plasma, and cell culture supernatants with high sensitivity (0.15ng/mL) and a detection range of 0.312-20ng/mL . Western blotting can also differentiate soluble from membrane-bound forms based on molecular weight differences.

To experimentally manipulate these forms, researchers can use recombinant soluble ALCAM (like ALCAM-Fc chimeras) to compete with membrane-bound forms, or employ enzymatic treatments to release membrane-bound ALCAM into soluble form. These approaches enable functional studies that distinguish the biological activities of each form in various experimental systems.

What role does ALCAM play in chicken tumor progression and metastasis?

While specific data on ALCAM in chicken tumors is limited, insights from human studies provide a framework for investigating its role in avian tumor biology:

ALCAM appears to play a significant role in tumor-endothelial interactions, particularly in promoting tumor embolism. Research in pancreatic cancer demonstrates that ALCAM mediates adhesion between tumor cells and endothelium, facilitating tumor cell entry into blood vessels and subsequent metastasis . The study concluded that ALCAM plays a key role in mediating tumor-endothelial cell interactions and enhancing tumor embolism, suggesting it could be a therapeutic target .

Interestingly, ALCAM's role in cancer appears context-dependent. High ALCAM expression on human melanoma cell lines appears pro-metastatic, while anti-metastatic activity has been reported in human breast cancer . This dual nature suggests that ALCAM's function may depend on the tumor type and microenvironment.

For researchers investigating ALCAM in chicken tumor models, these findings highlight the importance of examining both pro- and anti-metastatic functions, the specific mechanisms of tumor-endothelial interactions, and the contextual factors that determine ALCAM's role in different tumor types.

How does ALCAM contribute to the formation of the immunological synapse in avian models?

ALCAM makes several critical contributions to immunological synapse (IS) formation in avian immune systems:

The protein facilitates initial adhesion between antigen-presenting cells and T cells through its interaction with CD6. This interaction stabilizes the early immunological synapse, creating a foundation for subsequent molecular interactions . As noted in human studies, adhesion of ALCAM-expressing antigen presenting cells and CD6-expressing T cells stabilizes the early IS .

Beyond initial adhesion, ALCAM-CD6 interactions enhance CD3-mediated effects on T-cell proliferation, CD25 expression, and Th1 commitment . This enhancement suggests that ALCAM functions not just in adhesion but also in signal amplification within the developing immunological synapse.

The spatial organization of ALCAM within the synapse likely contributes to the segregation of signaling molecules into distinct activation clusters. This organization creates a conducive environment for sustained T-cell activation and proper signal transduction across the synaptic interface between immune cells.

Researchers studying avian immunological synapses should consider these multifaceted functions when designing experiments to investigate ALCAM's role in immune cell interactions and activation.

What are the optimal methods for expressing and purifying recombinant Chicken ALCAM?

Optimal expression and purification of recombinant Chicken ALCAM requires careful consideration of expression systems, construct design, and purification strategies:

For expression systems, mammalian cell lines (such as HEK293 or CHO cells) are preferred due to their ability to perform proper glycosylation and post-translational modifications essential for ALCAM function. Based on established approaches for human and mouse ALCAM, these systems produce properly folded, biologically active protein .

Construct design options include:

• His-tagged constructs: Human ALCAM has been successfully produced with C-terminal 6-His tags, facilitating purification while maintaining biological activity

• Fc-fusion proteins: Both human and mouse ALCAM have been produced as Fc chimeras (ALCAM-Fc), which enhance stability and facilitate purification

• Signal peptide inclusion: Proper secretion requires inclusion of an appropriate signal sequence

The purification strategy typically involves:

• Affinity chromatography (Ni-NTA for His-tagged proteins or Protein A/G for Fc-fusions)

• Ion-exchange chromatography to remove contaminants

• Size-exclusion chromatography for final polishing and buffer exchange

For storage, recombinant ALCAM should be maintained at -20°C to -70°C for long-term storage (up to 6 months) and at 2-8°C under sterile conditions for shorter periods (up to 1 month) . Repeated freeze-thaw cycles should be avoided to maintain protein integrity and activity.

How can researchers validate the biological activity of recombinant Chicken ALCAM in vitro?

Validating the biological activity of recombinant Chicken ALCAM requires a multi-faceted approach:

Cell adhesion assays provide a direct functional assessment. Following the approach used for mouse ALCAM, researchers can evaluate the ability of fluorescently labeled cells (1-5 × 10^6 cells/mL) to adhere to immobilized recombinant human CD6 Fc chimera (typically coated at 10 μg/mL) . The percentage of adhering cells serves as a quantitative measure of ALCAM activity.

Binding assays should confirm specific interactions with known partners. Surface plasmon resonance or ELISA-based methods can quantify binding to CD6 or other ALCAM molecules, establishing affinity constants and binding kinetics. These measurements provide important quality control parameters for different protein preparations.

T-cell activation assays assess ALCAM's ability to enhance immune responses. By measuring T-cell proliferation, cytokine production, or activation marker expression in response to immobilized recombinant ALCAM (typically at concentrations of 0.3-1.5 μg/mL), researchers can confirm the protein's immunomodulatory functions .

Western blotting can verify that the recombinant protein has the expected molecular weight (approximately 100-110 kDa) and is recognized by specific anti-ALCAM antibodies, confirming proper expression and folding .

These complementary approaches provide comprehensive validation of recombinant ALCAM's biological activity across multiple functional domains.

What ELISA methods are most suitable for detecting Chicken ALCAM in research samples?

For detecting Chicken ALCAM in research samples, sandwich ELISA methods offer the highest sensitivity and specificity:

Commercial kits such as the Chicken CD166 antigen (ALCAM) ELISA Kit provide standardized approaches with well-characterized performance parameters. These kits typically offer:

• Detection range of 0.312-20ng/mL

• Sensitivity of approximately 0.15ng/mL

• Validation for chicken serum, plasma, and cell culture supernatants

When developing custom ELISA protocols, researchers should consider:

• Capture antibody selection: Antibodies recognizing conserved epitopes ensure consistent detection

• Detection antibody optimization: Biotinylated detection antibodies with streptavidin-HRP systems maximize sensitivity

• Sample preparation: Different matrices (serum, tissue lysates, culture supernatants) may require specific dilutions or pre-treatment

• Standard curve preparation: Recombinant Chicken ALCAM at 0.15-20 ng/mL provides an appropriate calibration range

• Validation parameters: Intra- and inter-assay CV, linearity, and recovery should be determined for each sample type

For tissue expression studies, immunohistochemistry provides spatial information about ALCAM distribution. Using methods similar to those established for human ALCAM, researchers can visualize ALCAM localization within chicken tissues using specific antibodies at concentrations of 2-3 μg/mL .

These approaches enable comprehensive quantitative and qualitative assessment of ALCAM expression across diverse experimental conditions.

How can researchers use recombinant Chicken ALCAM to study T-cell activation pathways?

Recombinant Chicken ALCAM offers several approaches for investigating T-cell activation pathways:

Immobilized ALCAM provides a platform for T-cell stimulation experiments. By coating plates with recombinant ALCAM (typically at 0.3-1.5 μg/mL), researchers can engage CD6 on T cells and measure subsequent activation events . This approach can be combined with other stimuli (like anti-CD3 antibodies) to assess co-stimulatory functions.

For signaling pathway analysis, researchers can use ALCAM stimulation to trigger CD6-dependent signaling cascades. Previous studies have shown that CD6 engagement activates mitogen-activated protein kinase pathways, suggesting similar mechanisms may operate in chicken T cells . Western blotting for phosphorylated signaling proteins can map these pathways.

Competition assays using soluble recombinant ALCAM can disrupt cell-surface ALCAM-CD6 interactions. This approach helps determine the specific contribution of ALCAM-CD6 signaling to T-cell activation by comparing responses in the presence or absence of soluble competitor.

Flow cytometry provides a powerful tool for measuring T-cell responses to ALCAM stimulation. By analyzing activation markers (like CD25), proliferation dyes, or intracellular cytokines, researchers can quantify multiple aspects of T-cell activation in response to ALCAM engagement .

These methodologies collectively enable comprehensive analysis of how ALCAM-CD6 interactions contribute to chicken T-cell activation and differentiation.

How can researchers use recombinant Chicken ALCAM in tumor-endothelial interaction studies?

Recombinant Chicken ALCAM provides valuable tools for studying tumor-endothelial interactions in avian cancer models:

In vitro adhesion assays can quantify tumor cell binding to endothelial monolayers. Based on approaches demonstrated in pancreatic cancer research, researchers can use DiI-based cell labeling methods and electric cell-substrate impedance sensing (ECIS) to measure adhesion dynamics in real-time . These techniques reveal both the strength and kinetics of ALCAM-mediated tumor-endothelial interactions.

For mechanistic studies, researchers can employ:

• Blocking experiments using anti-ALCAM antibodies or soluble recombinant ALCAM to inhibit endogenous interactions

• Competitive binding assays with domain-specific ALCAM constructs to map interaction regions

• Signaling pathway analyses in both tumor and endothelial cells following ALCAM engagement

In vivo models can assess ALCAM's role in tumor embolism and metastasis. By introducing fluorescently labeled tumor cells expressing varying levels of ALCAM into the circulation of chicken embryo models, researchers can track vascular arrest, extravasation, and metastatic colony formation.

These approaches allow researchers to determine whether ALCAM plays similar roles in avian tumor progression as observed in human pancreatic cancer, where it enhances tumor embolism and represents a potential therapeutic target .

What are the recommended protocols for studying ALCAM-mediated homotypic versus heterotypic interactions?

Distinguishing ALCAM-mediated homotypic and heterotypic interactions requires specific experimental approaches:

For homotypic (ALCAM-ALCAM) interactions:

• Aggregation assays: Suspend single cells expressing ALCAM in calcium-containing buffer and quantify formation of cell clusters over time

• FRET-based methods: Label ALCAM molecules with donor and acceptor fluorophores to detect molecular proximity during homotypic binding

• Blocking studies: Use domain-specific antibodies to determine which regions of ALCAM mediate self-association

For heterotypic (ALCAM-CD6) interactions:

• Binding assays: Measure adhesion of CD6-expressing cells to surfaces coated with recombinant ALCAM (typically at 5-10 μg/mL)

• Flow cytometry: Use fluorescently labeled recombinant ALCAM to detect binding to CD6-positive cells

• Co-immunoprecipitation: Isolate ALCAM-CD6 complexes from mixed cell populations to confirm physical association

Comparative studies should include:

• Side-by-side comparison of binding affinities for homotypic versus heterotypic interactions

• Competition experiments where soluble ALCAM competes with cell-surface ALCAM for binding to partners

• Kinetic analyses comparing association and dissociation rates for different interaction types

These approaches provide mechanistic insights into how ALCAM mediates different types of cellular interactions in both physiological and pathological contexts.

How can researchers apply flow cytometry techniques to study ALCAM expression and function?

Flow cytometry offers powerful approaches for investigating ALCAM expression and function in chicken cell populations:

For expression analysis, direct immunostaining using fluorescently labeled anti-ALCAM antibodies (typically at 1-5 μg/mL) can quantify surface levels across different cell types . This approach enables identification of ALCAM-positive subpopulations within heterogeneous samples and correlation with other lineage or activation markers.

Binding studies can employ fluorescently labeled recombinant ALCAM to detect cells expressing CD6 or other binding partners. As demonstrated with human ALCAM, this approach can identify cells capable of interacting with ALCAM in complex mixtures .

For functional studies, researchers can:

• Perform cell sorting based on ALCAM expression to isolate populations for further analysis

• Combine ALCAM staining with activation markers to correlate expression with functional states

• Use fluorescent cell tracking dyes to monitor ALCAM-dependent cell-cell interactions

Advanced applications include imaging flow cytometry, which combines the quantitative power of flow cytometry with microscopic visualization. This technique allows assessment of ALCAM clustering, internalization, and colocalization with other molecules during cell-cell interactions .

These flow cytometry approaches provide both quantitative and qualitative information about ALCAM biology across diverse experimental systems.

What are the major challenges and future directions in Chicken ALCAM research?

Research on Chicken ALCAM presents several challenges and promising future directions:

Technical challenges include limited availability of chicken-specific reagents compared to mammalian systems. Researchers often need to validate cross-reactivity of existing antibodies or develop new tools specifically for avian studies. Additionally, the complex glycosylation pattern of ALCAM (resulting in a 100-110 kDa protein from a much smaller core protein) complicates expression and functional analysis .

Future research directions should focus on:

• Comparative analysis of ALCAM function across species to identify conserved and divergent mechanisms

• Development of chicken-specific ALCAM knockout models using CRISPR/Cas9 technology

• Investigation of ALCAM's role in avian-specific immune responses and developmental processes

• Exploration of ALCAM as a potential therapeutic target in avian diseases and as a model for human conditions

The increasing availability of recombinant protein tools and growing interest in comparative immunology suggest that chicken ALCAM research will continue to expand, providing valuable insights into both avian biology and evolutionarily conserved adhesion mechanisms that may inform human biomedical research .